Greenspring Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Buy
3,171
+64
+2% +$65.4K 0.21% 65
2026
Q1
$2.86M Buy
3,107
+66
+2% +$66.9K 0.17% 70
2025
Q4
$3.27M Buy
3,041
+2,541
+508% +$2.43M 0.2% 67
2025
Q3
$382K Buy
+500
New +$372K 0.07% 72
2025
Q1
$1.23M Buy
1,490
+250
+20% +$208K 0.29% 31
2024
Q4
$957K Sell
1,240
-250
-17% -$207K 0.21% 33
2024
Q3
$1.32M Hold
1,490
0.29% 25
2024
Q2
$1.35M Buy
1,490
+190
+15% +$152K 0.32% 22
2024
Q1
$1.01M Hold
1,300
0.25% 27
2023
Q4
$758K Hold
1,300
0.21% 28
2023
Q3
$698K Buy
1,300
+800
+160% +$412K 0.22% 28
2023
Q2
$234K Sell
500
-1,552
-76% -$651K 0.07% 56
2023
Q1
$705K Sell
2,052
-148
-7% -$49.9K 0.15% 56
2022
Q4
$805K Hold
2,200
0.21% 50
2022
Q3
$711K Hold
2,200
0.22% 50
2022
Q2
$714K Hold
2,200
0.21% 49
2022
Q1
$630K Sell
2,200
-8
-0.4% -$2.06K 0.17% 51
2021
Q4
$610K Buy
+2,208
New +$560K 0.16% 51

Other funds holding LLY

Greenspring Advisors's LLY Position: Q2 2026 in Review

Greenspring Advisors increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $65.4K and bringing the position to 3,171 shares worth $3.8M. The position accounts for 0.21% of the portfolio, ranked #65.

Greenspring Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Greenspring Advisors held 3,171 shares of Eli Lilly worth $3.8M as of Q2 2026.
  • Greenspring Advisors bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 0.21% of Greenspring Advisors's portfolio in Q2 2026, its #65 holding.
  • Greenspring Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.